Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1D1 | P20393 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | STAT1 | P42224 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31601866 | 0.93 | NR1D1 (0.33) | NR1D1NPC1ALDH1A1STAT1RAB9A | |
| SCHEMBL31601989 | 0.89 | ALDH1A1 (0.32) | NR1D1NPC1ALDH1A1STAT1RAB9A | |
| SCHEMBL31601786 | 0.86 | NR1D1 (0.35) | NR1D1NPC1ALDH1A1STAT1RAB9A | |
| SCHEMBL31601839 | 0.86 | NR1D1 (0.35) | NR1D1NPC1ALDH1A1STAT1RAB9A | |
| SCHEMBL31601945 | 0.83 | CDC25A (0.35) | NPC1ALDH1A1STAT1RAB9ASMN1; SMN2 | |
| SCHEMBL31601758 | 0.81 | NR1D1 (0.35) | NR1D1NPC1ALDH1A1STAT1RAB9A | |
| SCHEMBL31601925 | 0.79 | NPC1 (0.34) | NPC1ALDH1A1STAT1RAB9ASMN1; SMN2 | |
| SCHEMBL31601832 | 0.75 | PDE1B (0.36) | NR1D1 | |
| SCHEMBL31601903 | 0.75 | HDAC1 (0.32) | — | |
| SCHEMBL31601720 | 0.73 | THRB (0.36) | NR1D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110815-A1 | IMIDAZO [1,2-B] PYRIDAZINE-BASED NOVEL COMPOUND AS CDK INHIBITOR AND USE THEREOF | 아이리드비엠에스 주식회사 | 2025-05-30 | — | — | WO | disclosed |